Ceftriaxone Vs Levofloxacin on Cytokine Expression in Pneumococcal Pneumonia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00429975|
Recruitment Status : Terminated
First Posted : February 1, 2007
Last Update Posted : February 1, 2007
|Condition or disease||Intervention/treatment||Phase|
|Pneumonia, Pneumococcal||Drug: levofloxacin Drug: ceftriaxone||Phase 4|
Bacterial alveolar invasion is followed by a compartmentalized inflammatory response. Data suggest that some antimicrobials may induce a differential release of cytokines, with the potential of either accelerating or down regulating cytokine production.
The aim of our study was to compare the effects of ceftriaxone compared with levofloxacin on cytokine systemic concentrations in patients with pneumococcal pneumonia.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||45 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Comparison Between Ceftriaxone and Levofloxacin on Cytokine Expression Over Time in Severe Pneumococcal Pneumonia|
|Study Start Date :||August 2004|
|Study Completion Date :||September 2005|
- Circulating levels of pro and anti-inflammatory cytokines at 0h, 24, 72 h and 120 h from inclusion
- the relationship between cytokine expression, clinical variables and severity of disease.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00429975
|Hospital Mutua de Terrassa|
|Terrassa, Barcelona, Spain, 08221|
|Principal Investigator:||ESTHER CALBO, MD||Hospital Mutua de Terrassa|
|Principal Investigator:||MONTSERRAT ALSINA, MD||HOSPITAL MUTUA TERRASSA|
|Principal Investigator:||MARIONA XERCAVINS, MD||Hospital Mutua de Terrassa|
|Principal Investigator:||EVA CUCHI, MD||Hospital Mutua de Terrassa|
|Principal Investigator:||MONICA RODRIGUEZ-CARBALLEIRA, PhD||Hospital Mutua de Terrassa|
|Study Director:||JAVIER GARAU, PhD||Hospital Mutua de Terrassa|